Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Lisata Therapeutics (LSTA) Interest Expenses (2016 - 2018)

Lisata Therapeutics filings provide 9 years of Interest Expenses readings, the most recent being $2000.0 for Q2 2018.

  • For the quarter ending Q2 2018, Interest Expenses fell 99.02% year-over-year to $2000.0, compared with a TTM value of $2000.0 through Mar 2019, down 99.1%, and an annual FY2018 reading of $5000.0, down 98.68% over the prior year.
  • Interest Expenses hit $2000.0 in Q2 2018 for Lisata Therapeutics, down from $3000.0 in the prior quarter.
  • The five-year high for Interest Expenses was $926817.0 in Q1 2016, with the low at $2000.0 in Q2 2018.
  • Median Interest Expenses over the past 5 years was $193980.5 (2014), compared with a mean of $282022.1.
  • The sharpest move saw Interest Expenses surged 485.16% in 2015, then tumbled 99.02% in 2018.
  • Year by year, Interest Expenses stood at $372158.0 in 2014, then rose by 28.22% to $477178.0 in 2015, then crashed by 62.65% to $178236.0 in 2016, then tumbled by 96.69% to $5901.0 in 2017, then plummeted by 66.11% to $2000.0 in 2018.
  • According to Business Quant data, Interest Expenses over the past three periods came in at $2000.0, $3000.0, and $5901.0 for Q2 2018, Q1 2018, and Q4 2017 respectively.